Chiari malformation type 0: methodological concerns regarding the null structural finding Authors: Enver I. Bogdanov, John D. Heiss, Aisylu T. Faizutdinova Published: 2026 Dear Editor, The article by Candan and colleagues reached the conclusion that Chiari malformation type 0 (CM0) lacks a consistent structural substrate in the posterior cranial fossa (PCF) [5]. This conclusion contrasts with earlier studies that defined CM0 more narrowly and used more MRI morphometric measurements than Candan’s group. We speculate that Candan et al. reached different conclusions from previous research because their study selection criteria for CM0 patients differed from previous studies. The previous studies defined CM0 by obliteration of the cisterna magna and/or a small PCF with tonsils at the foramen magnum (FM) and associated syringomyelia (SM) [4, 6], Candan et al. defined it based solely on tonsillar ectopia < 3 mm, without requiring SM [5], resulting in their CM0 group including patients with tonsillar ectopia < 3 mm with and without SM. We acknowledge that some other studies had small or non-uniform CM0 cohorts [1, 8, 16, 17]. The Candan et al. study, unlike previous ones, did not exclude patients with secondary causes of tonsillar ectopia. These patients have a normal PCF. The differences in subject selection criteria could have resulted in the Candan et al. study findings not agreeing with previous studies that had identified that CM0 was associated with PCF hypoplasia, size reduction, flattening, reduced area surrounding the FM, and crowdedness in the FM [1, 3, 7, 8, 14, 16, 17]. Despite including patients without SM in their CM0 group, Candan’s article contains tables showing a trend of PCF hypoplasia in CM0 [5]. In their combined male/female cohorts, clivus length was shortest in CM1 (39.4 ± 6.0 mm), intermediate in CM0 (42.4 ± 4.6 mm), and longest in controls (43.5 ± 4.5 mm). The same progressive gradient was seen for PCF area: CM1 2961 ± 316 mm2, CM0 3125 ± 319 mm2, and controls 3172 ± 897 mm2. These trends were even more pronounced in females. The tentorial angle decreased from CM1 (39.15 ± 7.26) to CM0 (36.47 ± 5.61) to controls (35.77 ± 5.77) [5]. These gradients are less pronounced than previous studies but trend toward supporting prior studies that showed congenital PCF hypoplasia in both CM1 and CM0 [1, 3, 13, 14, 16, 17]. Candan et al. found significant differences only for CM1 versus controls, but this trend suggests they overstated in claiming that CM0 has “no consistent structural substrate.” We suspect that underpowered pairwise comparisons and inclusion of patients without SM in the CM0 group led to reduced evidence of PCF hypoplasia in Candan’s study. Genetic studies show heritability of small PCF volume and familial links between CM1 and CM0 [2, 8–10]. Several studies have found PCF hypoplasia in CM0. Sekula et al. reported reduced lengths of the clivus, basisphenoid, and basiocciput, and an increased angle of the tentorium in patients with tonsillar descent < 3 mm below the FM [16]. Nwotchouang et al. demonstrated that clivus length could distinguish symptomatic CM1 and CM0 from controls [14]. Nishikawa et al. identified CM-borderline/CM0 as localized occipital hypoplasia [13]. Other researchers emphasized that supraocciput measurement is critically important to include as an indicator of occipital hypoplasia. Candan et al. did not include supraocciput measurement [3, 5, 12, 15] Small PCF (SPCF) and tonsillar ectopia can lead to daily persistent headaches and cough headaches. SPCF may predispose individuals to complications such as post-lumbar puncture foramen magnum syndrome, trigeminal neuralgia, and increased criticality of PCF hemorrhage [2, 11, 18]. Recognizing SPCF accompanying tonsillar ectopia may avoid diagnostic and treatment delays. We suspect that Candan and colleagues’ reached the invalid conclusion that CM0 lacks a structural substrate because of their (1) lax inclusion criteria for CM0 (no SM required and secondary tonsillar ectopia not excluded); (2) disregarding a biologically meaningful data trend toward PCF hypoplasia in CM0; and (3) use of a limited set of PCF measurement parameters that omitted the supraocciput and other indicators of occipital hypoplasia. The significance of SPCF in CM0 is a controversial issue. In 2022, 81% of experts agreed with a consensus definition of CM0, up from 39% in 2019 [4, 6]. While some CM0 patients may have arachnoid adhesions alone, more often a thorough morphometric analysis finds occipital bone hypoplasia. We support Candan et al.'s views on inclusion of physiologic measurements in CM0 studies [5]. Future research of CM0 and related conditions within the CM1 spectrum should use validated morphometric assessments to evaluate the PCF size and geometry, and non-invasively measure CSF dynamics, intracranial compliance, CSF pressure, and flow vectors. We thank the editors for the opportunity to provide this critical perspective. Sincerely,